OKYO - OKYO Pharma Limited News

Discover

OKYO

OKYO Pharma Limited

1.57

1 x 1.47

1 x 1.59

bid

ask

+

0.08

5.37%

undefined @ 04:00 PM

1.57 +0.00 (0.00%)

Ytd	-24.15%
1y	-51.99%

1.53

day range

1.61

1.34

52 week range

3.33

Open	1.57	Prev Close	1.49	Low	1.53	High	1.61	Mkt Cap	60.24M
Vol	191.02K	Avg Vol	98.19K	EPS	-0.05	P/E	-31.27	Forward P/E	N/A
Beta	0.04	Short Ratio	4.64	Inst. Own	2.96%	Dividend	N/A	Div Yield	N/A
Ex Div Date	N/A	Earning	08-13	50-d Avg	1.57	200-d Avg	1.84	1yr Est	7.00

OKYO News

OKYO Pharma Says Chief Scientific Officer Raj Patil Purchases Of 3,363 Of Ordinary Shares On NASDAQ

OKYO Pharma Limited (NASDAQ:OKYO), a clinical-stage biopharmaceutical company developing investigati

OKYO Pharma Says CEO Robert Dempsey Purchases 15,000 Of Its Ordinary Shares On NASDAQ At $1.54 Per S

OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigat

OKYO Pharma Says Gary Jacob, Chief Development Officer And Director, Increases His Holdings With Pur

OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigat

OKYO Pharma Says Chief Medical Officer, Flavio Mantelli, Purchases 20,000 Of Its Ordinary Shares On

OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigat

OKYO Pharma Says Chairman Gabriele Cerrone, Through Panetta Partners, Increases His Holdings With Pu

OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigat

OKYO To Initiate Global Phase 3 NEPTUNE Trial In Neuropathic Eye Pain, Enrolling 111 Patients Across

OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigat

HC Wainwright & Co. Maintains Buy on OKYO Pharma, Lowers Price Target to $5

HC Wainwright & Co. analyst Yi Chen maintains OKYO Pharma (NASDAQ:OKYO) with a Buy and lowers

12 Health Care Stocks Moving In Friday's After-Market Session

12 Health Care Stocks Moving In Friday's After-Market Session

Gainers Q32 Bio (NASDAQ:QTTB) stock moved upwards by 44.4% to $16.19 during Friday's after-mark

12 Health Care Stocks Moving In Tuesday's After-Market Session

12 Health Care Stocks Moving In Tuesday's After-Market Session

This Pfizer Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Friday

This Pfizer Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Friday

12 Health Care Stocks Moving In Friday's Pre-Market Session

12 Health Care Stocks Moving In Friday's Pre-Market Session

12 Health Care Stocks Moving In Friday's After-Market Session

12 Health Care Stocks Moving In Friday's After-Market Session

12 Health Care Stocks Moving In Friday's Intraday Session

12 Health Care Stocks Moving In Friday's Intraday Session

12 Health Care Stocks Moving In Thursday's After-Market Session

12 Health Care Stocks Moving In Thursday's After-Market Session

12 Health Care Stocks Moving In Wednesday's After-Market Session

12 Health Care Stocks Moving In Wednesday's After-Market Session

12 Health Care Stocks Moving In Thursday's Intraday Session

12 Health Care Stocks Moving In Thursday's Intraday Session

12 Health Care Stocks Moving In Friday's Pre-Market Session

12 Health Care Stocks Moving In Friday's Pre-Market Session

12 Health Care Stocks Moving In Friday's After-Market Session

12 Health Care Stocks Moving In Friday's After-Market Session

12 Health Care Stocks Moving In Wednesday's After-Market Session

Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday'

Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acqu

Why Nikola Dropped Over 9%; Here Are 66 Biggest Movers From Yesterday

Gainers Mobile Global Esports Inc. (NASDAQ: MGAM) shares surged 103.9% to settle at $5.30 on Tues

Stocks That Hit 52-Week Lows On Tuesday

On Tuesday, 540 companies set new 52-week lows.

Stocks That Hit 52-Week Lows On Wednesday

On Wednesday, 216 stocks hit new 52-week lows.